Mall owners are increasingly building out food halls with local chef-driven eateries, sushi bars and premium coffee shops.Retailread more
Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
While Trump's lawyers had argued that the committee's subpoena did not have a legitimate legislative purpose — and was therefore invalid — Mehta took a broader view.Politicsread more
See which stocks are posting big moves after the bell on Monday, May 20.Market Insiderread more
Silicon Valley argues that Wall Street focuses too much on near-term profits — but investors have embraced money-losing biotech IPOs.Marketsread more
Iran has quadrupled its output of nuclear material amid rising tension with the U.S. and dangerous escalations in the Middle East.Energyread more
The announcement comes amid a wave of store closures across the country this year.Retailread more
"As long as President [Donald] Trump believes that the Chinese are the ones who pay the price, he's going to keep taking a hard-line approach to these negotiations," Cramer...Mad Money with Jim Cramerread more
Sens. Mitch McConnell and Tim Kaine introduced a bill Monday that would raise the minimum age to buy tobacco to 21 in hopes of curbing what regulators are calling an...Health and Scienceread more
More tit-for-tat tariffs in the U.S.-China trade war could set the global economy up for a recession, according to Morgan Stanley.Marketsread more
Team collaboration app Slack is now seeking to trade under the symbol "WORK," instead of the symbol it had first applied to use, "SK."Technologyread more
Forbes magazine on Wednesday reduced its estimate of the net worth of Elizabeth Holmes, the founder and chief executive of health technology company Theranos, to zero from $4.5 billion last year.
Holmes' blood-testing company has been under investigation by several federal and state agencies and was accused in a suit filed last week of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers.
Forbes said private investors had bought stakes in Theranos that implied a $9 billion valuation but said $800 million is a more realistic figure.
"At such a low valuation, Holmes' stake is essentially worth nothing," the business publication said.
Theranos spokeswoman Brooke Buchanan responded to the report saying, "As a privately held company, we declined to share confidential financial information with Forbes. As a result, the article was based exclusively on speculation and press reports. "
In 2015 Forbes had named Holmes the richest self-made woman in America. Explaining why it reduced its estimate of Holmes' wealth for the same list this year, Forbes said her fortune was based entirely on her 50 percent stake in Theranos, a stake that has suffered in value amid questions over the company's diagnostic capabilities.
"According to VC Experts, investors in Theranos own a particular kind of preferred equity, called participating preferred shares, which take precedence to common stock in the event of a liquidation," Forbes said. "Forbes is not aware of any plans to liquidate. If that were to happen, participating preferred investors would get their money back and more before Holmes gets a cent. "
Holmes did not immediately respond to a request for comment.
Holmes founded Theranos in 2003 and it promised ground-breaking methods that would allow quick results for a wide range of tests with just one drop of blood. Reports in The Wall Street Journal said the testing devices were flawed and had problems with accuracy.
The company has been investigated by federal prosecutors, the U.S. Securities and Exchange Commission, state health departments in Arizona and Pennsylvania, the Centers for Medicare and Medicaid and the U.S. Food and Drug Administration.